AbbVie (ABBV) Protective Put Calculator
Calculator · free · no signup · ABBVPrice a protective put, zero-cost collar, or put spread on AbbVie. Annual cost, max loss, upside cap, tax treatment, auto-filled from current ABBV option chain.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.
Request beta access →Related calculators: Stock Concentration Calculator
About AbbVie
AbbVie (ABBV) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in North Chicago, IL.
Last close: $261.59 per share (as of 2026-10-01).
Equity grants at AbbVie typically include restricted stock units (RSUs).
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Source: Wikipedia (CC BY-SA 4.0)
AbbVie separated from Abbott Laboratories on January 1, 2013, becoming an independent, publicly traded research-based pharmaceutical company headquartered in North Chicago, Illinois. It develops and markets prescription medicines in immunology (Skyrizi, Rinvoq), oncology, neuroscience, and aesthetics, the last added through its 2020 acquisition of Allergan (maker of Botox Cosmetic). The company employs roughly 55,000 people worldwide and grants equity compensation, including RSUs (restricted stock units, shares that vest over time) and stock options, as part of employee pay. AbbVie reported record full-year 2025 net revenue of $61.2 billion, up 8.5% operationally, with immunology products contributing $30.4 billion of that total.
Sources: sec.gov · investors.abbvie.com · en.wikipedia.org
Equity comp at AbbVie
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by AbbVie.
A protective put caps your downside on the ABBV position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current ABBV option chain, with annual cost, max loss, and tax-treatment notes.
Example: a 5,000-share ABBV position at $261.59 is worth $1,307,950. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $26,159 to $52,318) before any premium offset from a short call. The calculator prices both structures off ABBV's current option chain so you see the actual cost for your chosen floor, tenor, and cap.
All AbbVie tools → · Use the generic Protect Your Stock Calculator for any company.
AbbVie equity questions
- How much does it cost to hedge ABBV stock?
- The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and ABBV's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current ABBV option chain and shows the annual cost, maximum loss, and tax treatment.
- Does AbbVie grant ISOs, NSOs, or RSUs?
- Equity compensation at AbbVie typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do AbbVie RSUs use double-trigger vesting?
- No. AbbVie restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your AbbVie equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.